Vaccinens sikkerhed blev vurderet i forskellige, kontrollerede undersøgelser, hvori mere end 18. 000 raske børn (i alderen 6 uger til 18 måneder) indgik.
The safety of the vaccine was assessed in different controlled clinical studies in which more than 18,000 healthy infants (6 weeks to 18 months) were included.